Aurobindo Pharma Limited has received final approvals from the US Food & Drug Administration (USFDA) for 2 ANDAs namely Cefotaxime for Injection USP 500mg, 1g, 2g and Cefotaxime for Injection USP 10g pharmacy bulk pack.

Cefotaxime for Injection is the generic equivalent to Claforan for injection of Sanofi Aventis US, LLC. Cefotaxime for Injection and falls under the Anti-betallactum segment and is ready for launch.

Aurobindo now has a total of 109 ANDA approvals (80 Final approvals and 29 Tentative approvals) from USFDA.